David T. Curiel BA, MD, PhD

David T. Curiel, MD, PhD, is a tenured professor in the Cancer Biology Division of the Department of Radiation Oncology. Dr. Curiel graduated medical school at Emory University in 1982, where he also completed his internship and residency in Internal Medicine. Dr. Curiel’s scientific training includes tenureship at the National Institutes of Health in Bethesda, Maryland at the Pulmonary Branch of the Heart and Lung, and Blood Institute (NHLBI) from 1985-1989, and a fellowship in Biotechnology at the National Cancer Institute, Navy Medical Oncology Branch from 1989-1990.

He received his Ph.D. from University of Groningen in The Netherlands in 2002. Dr. Curiel has been at Washington University School of Medicine since 2011 and is the Director of the Biologic Therapeutics Center. His work is focused on gene transfer vectors to advance the human application of gene therapy, virotherapy, and vaccinology. His oncolytic virotherapy for glioblastoma is fast track for FDA approval. He is also the editor in chief for the Journal of Ovarian Research.